Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
4
×
boston
roche
san francisco blog main
san francisco top stories
avapritinib
blueprint medicines
clinical trials
deals
eli lilly
europe blog main
europe top stories
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
aimmune therapeutics
allergy
anaphylaxis
andrew oxtoby
biopharma
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
capmatinib
cstone pharmaceuticals
daniel edelman
detroit blog main
detroit top stories
What
approval
4
×
fda
drug
therapy
blueprint
cancer
medicines
ret
roche
therapeutics
won
address
agency
aimmune
allergy
approved
approves
awarded
betting
billion
biopharma
candidate
carries
certain
currently
deal
designed
developed
duchenne
friday
gene
genetic
historic
immunotherapy
late
latest
marketing
medicine
muscle
oral
Language
unset
4
×
Current search:
approval
×
" national top stories "
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal